DELPHX ANNOUNCES CLOSING OF NON-BROKERED UNIT PRIVATE PLACEMENT
MWN-AI** Summary
DelphX Capital Markets Inc. (TSXV: DELX; OTCQB: DPXCF), a pioneer in structured products, announced the successful closing of its non-brokered private placement on February 25, 2026. Initially announced on February 18, the offering included the issuance of 4,100,000 units at a price of C$0.05 per unit, yielding gross proceeds of C$205,000. Each unit is comprised of one common share and an associated common share purchase warrant, which allows the holder to buy one additional common share at a price of C$0.08 over a two-year period.
The completion of this private placement is subject to the approval of the TSX Venture Exchange, with securities issued being subject to a hold period of four months plus one day from issuance. The net proceeds are intended to support the company's working capital and corporate overhead costs.
DelphX specializes in developing and providing innovative structured products, operating through its special purpose vehicle, Quantem LLC. The firm focuses on creating private placement securities that cater to financial market demands for fixed income and cryptocurrency solutions. Among its proprietary offerings are Collateralized Put Options (CPOs) and Collateralized Reference Notes (CRNs), which are designed to provide investors protection against rating downgrades and potential losses in both corporate bonds and cryptocurrency investments. All CPOs and CRNs are fully collateralized and held securely by US Bank.
These developments underscore DelphX's commitment to pioneering new financial instruments and addressing the evolving needs of both retail and institutional investors. For further information about DelphX, please visit their official website.
MWN-AI** Analysis
DelphX Capital Markets Inc. (TSXV: DELX; OTCQB: DPXCF) recently announced the successful closure of a non-brokered private placement, generating C$205,000 by issuing 4,100,000 units at C$0.05 each. This strategic move highlights DelphX's commitment to enhancing its capital structure and bolstering its operational capabilities as it continues to innovate in structured products, particularly with its Collateralized Put Options (CPOs) and Collateralized Reference Notes (CRNs).
From an investment perspective, the completion of this private placement may present a favorable opportunity for potential investors. The issuance of these units, which also include warrants priced at C$0.08, allows existing and new investors to participate in the upside potential while minimizing their entry cost. With warrants expiring in two years, they offer a speculative angle; if DelphX’s products gain traction, the stock could rise above the warrant exercise price, rewarding investors.
Furthermore, DelphX is pioneering a niche market by providing structured products that merge traditional finance with cryptocurrency solutions. This innovation positions the company uniquely within the financial services landscape, appealing to qualified institutional buyers looking for both security and yield in volatile markets.
However, potential investors must remain cautious. The company is still subject to TSX Venture Exchange's approval, and the four-month hold period on new securities introduces a timeframe for liquidity considerations. Market sentiment regarding frequently emerging financial instruments, such as those linked to cryptocurrency, can also lead to increased volatility.
In conclusion, while the potential for growth in DelphX's innovative product line is notable, investors should weigh this against the inherent risks and market conditions. Monitoring future developments and the broader market landscape will be essential for making informed investment decisions in DelphX Capital Markets.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Toronto, ON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) (“DelphX”), a leader in the development of new classes of structured products, announces that it has closed its non-brokered private placement previously announced on February 18, 2026 issuing 4,100,000 units (the “Units”) at a subscription price of C$0.05 per Unit, for gross proceeds of C$205,000 (“the Offering”). Each Unit consists of one common share (“Common Share”) and one Common Share purchase warrant (“Warrant”). Each Warrant entitles the holder to purchase one Common Share at a price of $0.08, for a period of two years from the date of issuance.
Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance.
DelphX intends to use the net proceeds from the Offering in connection with working capital/corporate overhead.
About DelphX Capital Markets Inc.
DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:
- Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;
- Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.
All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.
For more information about DelphX, please visit www.delphx.com
George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
FAQ**
How does DelphX Capital Markets Inc. (DPXCF) plan to leverage the proceeds from their recent private placement to enhance their structured product offerings in the financial market?
What measures is DelphX Capital Markets Inc. (DPXCF) implementing to ensure the successful distribution and market acceptance of its new proprietary products, like CPOs and CRNs?
In the context of DelphX Capital Markets Inc. (DPXCF), what role do announcements like the recent private placement have on investor confidence and stock performance?
How does DelphX Capital Markets Inc. (DPXCF) differentiate its collateralized products from traditional structured products in terms of risks and returns offered to institutional investors?
**MWN-AI FAQ is based on asking OpenAI questions about Delphx Capital Markets Inc. (OTC: DPXCF).
NASDAQ: DPXCF
DPXCF Trading
0.0% G/L:
$0.033 Last:
30,000 Volume:
$0.033 Open:
